Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Neuroendocrine Tumors × Positron Emission Tomography Computed Tomography × Clear all

Phase

Phase 2 2 Phase 1 2 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Prostatic Neoplasms 1 Neuroendocrine Tumors 1 Disease 1

Interventions

Octreotide 4 lanreotide 2 Everolimus 2 surufatinib 1 pasireotide 1 gadoteridol 1 gadoterate meglumine 1 gadolinium ethoxybenzyl DTPA 1 gadodiamide 1 gadobutrol 1 gadobenic acid 1 arginyllysine 1 Surveys and Questionnaires 1 Sunitinib 1 Somatostatin 1 Positron Emission Tomography Computed Tomography 1 Neuropsychological Tests 1 Cisplatin 1 Carboplatin 1 Cabergoline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02621541 2016-01-06

Nonfunctional Pancreatic NET and PET Imaging

Turku University Hospital

Phase 4 Unknown

Disease, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡